Johnson
Josue Bacaltchuk, Vice President of Medical Affairs for Latin America at Janssen, J’s Belgian unit
“We expect the majority in Brazil because it is the largest country and also the maximum affected by the pandemic, so we expect many others to volunteer, but we also expect the best numbers in Colombia and Argentina.Bacaltchuk said.
“It is the company’s goal to prioritize countries that contribute to vaccine progression and will involve patients in trials, yes,” he added in an interview with Reuters on Thursday.
J vaccine
The drug manufacturer is testing in the United States and Belgium, and has added Chile, Argentina and Peru to a list of Latin American countries where it plans to conduct Phase III trials with Brazil, Colombia and Mexico.
Your international trials will come with 60, 000 volunteers.
All Latin American countries have the highest number of infections, making them exciting verification sites for vaccine developers, as it is to download reliable verification effects in spaces with the highest rates of active transmission and infection.
Bacaltchuk said the resolve to publish the trials largely motivated the challenge of ensuring that sufficient numbers of volunteers in a domain populated through other pharmaceutical corporations conduct trials of their own prototypes.
“I think it’s a forward-looking threat and that’s why we move to a number of higher centers than other corporations to cover geographic spaces that aren’t covered by other studios,” he said.
He the reaction of the volunteers of the region has been “quite positive” and hopes that it will continue.
“This has an effect on everyone and will continue to have an effect even after the end, the consequences will continue, so we will have to review it to prevent it as soon as possible,” he said.
Coronavirus Essential SC rejects the request for neet deferral, JEE; U.S. states have not been able to do so.But it’s not the first time They should be able to distribute vaccines until 1 November.